HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI cbiit; appropriated; expand data commons; 09/14/18-09/13/23

Active Awarded Last action

Contract number
75N91018F00071
Awardee
Awarding agency
Obligated
$72,263,032

Award facts

Contract value 100% obligated
$72,263,032.00 Current and potential, with all options
Completion date 74% complete
Current and potential, with all options
NAICS code
561210 Facilities Support Services
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00014 $5,250,000
Other Administrative Action P00013 $0
Exercise an Option P00012 $21,434,446
Other Administrative Action P00011 $0
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 $0
Funding Only Action P00007 -$1,248,091
Other Administrative Action P00006 $7,997,809
Other Administrative Action P00005 $10,558,132
Funding Only Action P00004 $9,600,000
Other Administrative Action P00003 $0
Funding Only Action P00002 $10,500,000
Other Administrative Action P00001 $0
Original award $8,170,736
Show all 15

About this award

Written by GovTribe AI ·

The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 11, 2018, under the HHSN261201500003I indefinite delivery contract with a ceiling value of $72.3 million and ultimate completion date of August 31, 2029.

HHSN261201500003I is a cost-plus-fixed-fee indefinite delivery contract supporting biomedical research and facilities operations for the National Cancer Institute. Place of performance is Frederick, Maryland.

Work spans research execution, clinical trial support, facilities infrastructure management, and specialized manufacturing including monoclonal antibody production, gene therapy vector manufacturing, vaccine platform development, and chemistry, manufacturing, and controls development of therapeutic candidates. Facilities work includes building renovations, infrastructure improvements, and campus support at the Frederick National Laboratory for Cancer Research.

Service Contract Inventory reporting shows actual government-invoiced labor across fiscal years 2021–2025: FY2021 invoiced $7.2 million (15.6 FTEs, 32,389 contractor hours at $221.21/hr); FY2022 invoiced $8.7 million (26.2 FTEs, 54,682 contractor hours at $158.77/hr); FY2023 invoiced $8.8 million (28.0 FTEs, 58,222 contractor hours at $151.29/hr); FY2024 invoiced $9.9 million (18.4 FTEs, 38,390 contractor hours at $256.89/hr); FY2025 invoiced $6.9 million (13.0 FTEs, 26,978 contractor hours at $255.99/hr). In FY2025, 63 percent of contractor hours were subcontracted to eight named subcontractors. Derived government-paid hourly rates show an upward trend from FY2023 to present.

Quick answers

Who was awarded contract 75N91018F00071?

75N91018F00071 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 11, 2018.

How much is contract 75N91018F00071 worth?

The government has obligated $72,263,032 on 75N91018F00071.

Is contract 75N91018F00071 an order under another contract?

Yes. 75N91018F00071 is a delivery order under HHSN261201500003I, an indefinite delivery contract.

Was contract 75N91018F00071 competed?

The extent of competition for 75N91018F00071 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login